Found 0 matching trials
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
PHASE1The purpose of this study is to evaluate the safety and preliminary clinica...
Location
Sarah Cannon Research Institute at Health One
PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)
N/ABackground:
There is significant variation in how clinicians currently pre...
Location
Manchester University NHS Foundation Trust
A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease
PHASE2The purpose of this study is to measure effects on CSF biomarkers, EEG and ...
Comparison of Aerobic Training and Circuit Training in Healthy Children
NAChildhood obesity is a growing concern, with potential consequences for lon...
Location
Multiple Locations
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
PHASE1This is a multicenter Phase 1b, open-label study to evaluate the pharmacoki...
Location
Fondazione IRCCS Istituto Nazionale Dei Tumori
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
PHASE3The purpose of this study was to evaluate safety and efficacy of the combin...
Location
California Cancer Associates for Research and Excellence
Relationships Between OLST, GMFM and Pedobarographic Values in CP
NAThe primary aim of this study was to investigate the relationship between t...
Location
Istanbul Kültür University
Ballistic Strength Training in Stroke: A Pilot Study
NAThis pilot study intends to evaluate whether stroke patients can complete b...
Location
Alfred Health - Caulfield Hospital
Regulatory T Cells for Amyotrophic Lateral Sclerosis
PHASE1Phase 1 Safety Run-in Study of 6 patients followed by Phase 1b Randomized, ...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
PHASE2This is a randomized single-institution, phase II, open-label clinical tria...
Location
University of California, San Francisco